Cascadian Therapeutics Inc (CASC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2005 | 03-2005 | 12-2004 | 09-2004 | 06-2004 | |
| Sales | 1,120 | 656 | 799 | 408 | 4,863 |
| Gross Profit | 910 | 660 | 1,450 | 410 | 4,840 |
| Operating Expenses | 5,170 | 4,600 | 5,200 | 4,040 | 4,300 |
| Operating Income | -4,050 | -3,944 | -4,401 | -3,632 | 563 |
| Interest Expense | 0 | 0 | 0 | 2 | 0 |
| Other Income | 140 | 344 | 591 | -126 | 207 |
| Pre-tax Income | -3,910 | -3,600 | -3,810 | -3,760 | 770 |
| Income Tax | 0 | 0 | -360 | 10 | 10 |
| Net Income Continuous | -4,803 | -3,558 | -2,936 | -3,695 | 758 |
| Net Income | $-4,803 | $-3,558 | $-2,936 | $-3,695 | $758 |
| EPS Basic Total Ops | -2.16 | -0.30 | -1.44 | -1.80 | 0.36 |
| EPS Basic Continuous Ops | -2.20 | -0.29 | -1.45 | -1.83 | 0.38 |
| EPS Diluted Total Ops | -2.16 | -0.30 | -1.44 | -1.80 | 0.36 |
| EPS Diluted Continuous Ops | -2.20 | -0.29 | -1.45 | -1.83 | 0.38 |
| EBITDA(a) | $-4,050 | $-3,884 | $-4,131 | $1,088 | $-3,977 |